Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer

由 Schneider, T, Sevko, A, Heussel, C P, Umansky, L, Beckhove, P, Dienemann, H, Safi, S, Utikal, J, Hoffmann, H, Umansky, V
發表在 Clin Exp Immunol (2015)